Cyclacel Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Cyclacel Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Cyclacel Pharmaceuticals Inc
Rating: 0.78258325
Author: Trendlyne DVM scores

about

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including C...

7.12 -0.34 (-4.56%)

98.81% Fall from 52W High

81,010

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.8 / 100

Technically Bearish

25.5 / 100

1Yr Price target downside is -86%

1 analysts

Cyclacel Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cyclacel Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including C...

98.81% Fall from 52W High

SWOT Analysis

Cyclacel Pharmaceuticals Inc Live Price Chart